Put the counseling back in genetics.

June 26, 2017. Among 33% of women with high-risk breast cancer, just over half received appropriate genetic counseling or testing despite over 80% desiring such testing. Most eligible patients said their doctor didn't recommend it. And it doesn't stop there. We are also pretty bad with counseling patients after those tests. Patients whose genetic testing shows mutations of unknown significance are just as likely as those with known high-risk mutations to have prophylactic bilateral mastectomies. Bottom line: It's important to test appropriately and even more important to make sure the results appropriately guide decisions.


Popular Posts